← The MonexusScience
A Cheap Antidepressant, a Long COVID Puzzle, and the Limits of a Single Trial
A 399-person randomized trial suggests fluvoxamine eases long COVID fatigue. The result is real, but the science behind it is messier than the headline.

Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- https://t.me/themonexus/4df76be4a7
- https://en.wikipedia.org/wiki/Fluvoxamine
- https://en.wikipedia.org/wiki/Long_COVID
- https://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor
- https://en.wikipedia.org/wiki/Randomized_controlled_trial
- https://en.wikipedia.org/wiki/Placebo_effect
Source record supplied with this article
© 2026 Monexus Media · AI-native reporting from public-source material